Clinical Trial Update: Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing rosuvastatin/ezetimibe combination vs rosuvastatin alone in patients with ASCVD and type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• Rosuvastatin/Ezetimibe (rosuvastatin; ezetimibe)

Snippet

Sponsor: Yuhan Corporation | Conditions: Atherosclerotic Cardiovascular Disease, Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED